UNBS-5162

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameUNBS-5162

Drug Alias NameUNBS-5162

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAngiogenesis inhibitorsChemokines inhibitors

TargetsChemokines

Therapy Area/IndicationsLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUnibioscreen

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesDrais Unibioscreen

Active IndicationsN/A

Inactive IndicationsLymphoma

ATC CodeN/A